United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 714,900 | 677,700 | 614,700 | 609,400 | 596,500 |
| Cost of Goods | 77,800 | 72,900 | 71,000 | 70,100 | 64,100 |
| Gross Profit | 637,100 | 604,800 | 543,700 | 539,300 | 532,400 |
| Operating Expenses | 318,000 | 249,400 | 283,600 | 212,400 | 219,100 |
| Operating Income | 319,900 | 356,300 | 260,100 | 327,000 | 313,400 |
| Interest Expense | 11,600 | 13,300 | 15,100 | 15,600 | 14,800 |
| Other Income | 47,000 | 55,600 | 50,400 | 40,400 | 36,600 |
| Pre-tax Income | 355,300 | 398,600 | 295,400 | 351,800 | 335,200 |
| Income Tax | 77,200 | 92,000 | 78,300 | 84,200 | 76,000 |
| Net Income Continuous | 278,100 | 306,600 | 217,100 | 267,600 | 259,200 |
| Net Income | $278,100 | $306,600 | $217,100 | $267,600 | $259,200 |
| EPS Basic Total Ops | 6.26 | 6.52 | 4.60 | 5.71 | 5.53 |
| EPS Basic Continuous Ops | 6.26 | 6.52 | 4.61 | 5.71 | 5.53 |
| EPS Diluted Total Ops | 5.85 | 6.17 | 4.33 | 5.38 | 5.24 |
| EPS Diluted Continuous Ops | 5.85 | 6.17 | 4.34 | 5.38 | 5.24 |
| EPS Diluted Before Non-Recurring Items | 5.85 | 6.17 | 4.36 | N/A | N/A |
| EBITDA(a) | $338,600 | $371,300 | $273,800 | $340,300 | $326,300 |